Actively Recruiting
Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic
Led by University of Monastir · Updated on 2024-09-19
1500
Participants Needed
1
Research Sites
85 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, randomized, single-blind study. Patients included in the study after successful treatment of the acute attack were randomized upon discharge from the Emergency Department into three groups: oral paracetamol-tramadol group, oral paracetamol-caffeine group and oral placebo group.
CONDITIONS
Official Title
Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years old.
- Consent to participate in the study.
- Sudden pain in the flank or lower back with urine test and/or imaging confirming renal colic.
- Pain score at discharge less than 30 on a visual analog scale from 0 to 100.
You will not qualify if you...
- Unable to rate pain using the visual analog scale.
- Pregnant or breastfeeding women.
- Kidney failure with creatinine clearance below 60 ml/min.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Semir Nouira
Monastir, Tunisia
Actively Recruiting
Research Team
K
Khaoula Bel Haj Ali
CONTACT
S
Semir Nouira, Pr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here